Recent advances in precision medicine for individualized immunosuppression.

Current Opinion in Organ Transplantation
Shengyi Fu, Ali Zarrinpar

Abstract

The current tools to proactively guide and individualize immunosuppression in solid organ transplantation are limited. Despite continued improvements in posttransplant outcomes, the adverse effects of over-immunosuppression or under-immunosuppression are common. The present review is intended to highlight recent advances in individualized immunosuppression. There has been a great focus on genomic information to predict drug dose requirements, specifically on single nucleotide polymorphisms of CYP3A5 and ABCB1. Furthermore, biomarker studies have developed ways to better predict clinical outcomes, such as graft rejection. The integration of advanced computing tools, such as artificial neural networks and machine learning, with genome sequencing has led to intriguing findings on individual or group-specific dosing requirements. Rapid computing allows for processing of data and discovering otherwise undetected clinical patterns. Genetic polymorphisms of CYP3A5 and ABCB1 have yielded results to suggest varying dose requirements correlated with race and sex. Newly proposed biomarkers offer precise and noninvasive ways to monitor patient's status. Cell-free DNA quantitation is increasingly explored as an indicator of allograft injury...Continue Reading

References

May 10, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nasrullah A Undre
Jul 5, 2013·The New England Journal of Medicine·Manikkam SuthanthiranUNKNOWN Clinical Trials in Organ Transplantation 04 (CTOT-04) Study Investigators
Nov 18, 2015·Circulation·Rahul C Deo
Dec 17, 2015·The Pharmacogenomics Journal·K SanghaviP A Jacobson
Mar 6, 2016·World Neurosurgery·Ruth E Bristol
Mar 9, 2017·Omics : a Journal of Integrative Biology·Toshiaki NakanoChao-Long Chen
Mar 11, 2017·Journal of the American Society of Nephrology : JASN·Roy D BloomUNKNOWN Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Stud
Apr 4, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A AsareL A Turka
May 19, 2017·SLAS Technology·Dean Ho, Ali Zarrinpar
Jan 5, 2018·Current Drug Metabolism·Katharina Schutte-NutgenStefan Reuter
Mar 14, 2018·JAMA : the Journal of the American Medical Association·Andrew L Beam, Isaac S Kohane
Mar 20, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiao ZhangJinming Li
May 8, 2018·Gastroenterology Clinics of North America·Andrew ZhuBrendan Keating
May 29, 2018·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Maral BakirMartin Cadeiras
Aug 16, 2018·International Journal of Radiation Oncology, Biology, Physics·Anna M DinklaCornelis A T van den Berg
Aug 21, 2018·Omics : a Journal of Integrative Biology·Dmitry GrapovSakda Khoomrung
Dec 7, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Abbie D LeinoJennifer M Rohan
May 3, 2019·Therapeutic Drug Monitoring·Mercè BrunetStein Bergan
Jun 1, 2014·Journal of Medical Imaging and Radiation Sciences·Lu Liu
Aug 11, 2019·Transplantation Proceedings·Mohammad Bilal SiddiquiM Shadab Siddiqui
Nov 7, 2019·Diabetes Technology & Therapeutics·Scott M PappadaThomas J Papadimos

❮ Previous
Next ❯

Citations

Dec 15, 2020·World Journal of Transplantation·Tess McClureAdam G Testro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
François GlowackiChristelle Cauffiez
Pharmacogenomics
Murielle BochudChin B Eap
Journal of Hepatology
David H AdamsDidier Samuel
© 2022 Meta ULC. All rights reserved